Datasets

138 datasets across 4 collections, loaded as polars DataFrames.

ADaM (pharmaverse)

31 datasets from pharmaverseadam.

Dataset	Label	Rows	Columns
adab	Anti-Drug Antibody Analysis Dataset	6,430	72
adae	Adverse Events Analysis	1,191	107
adapet_neuro	Amyloid PET Scan Analysis Dataset	83	49
adbcva_ophtha	Best Corrected Visual Acuity Analysis	7,672	71
adce_vaccine	Clinical Events Analysis for Vaccine	44	56
adcm	Concomitant Medications Analysis	7,510	95
adcoeq_metabolic	Questionnaires Analysis for Metabolic	1,110	85
adeg	Electrocardiogram Tests Analysis	78,756	108
adex	Exposure Analysis	6,315	92
adface_vaccine	Findings About Clinical Events Analysis	371	61
adis_vaccine	Immunogenicity Specimen Assessments	64	103
adlb	Laboratory Analysis	83,652	115
adlb_metabolic	Laboratory Analysis for Metabolic	371	43
adlb_neuro	Laboratory Analysis for Neuroscience	185	48
adlbhy	Analysis of Lab Hy’s Law	251	14
admh	Medical History Analysis	1,818	114
adnv_neuro	Nervous System Analysis Dataset	30	43
adoe_ophtha	Exam Analysis for Ophthalmology	19,136	103
adpc	Pharmacokinetic Concentrations	4,479	128
adpp	Pharmacokinetic Parameters	2,688	79
adppk	Population Pharmacokinetic	3,522	61
adrs_onco	Tumor Response Analysis	3,694	79
adsl	Subject Level Analysis	306	55
adsl_vaccine	Subject Level Analysis for Vaccine	2	46
adtpet_neuro	Tau PET Scan Analysis Dataset	34	46
adtr_onco	Tumor Results Analysis for Oncology	181	99
adtte_onco	Time to Event Analysis for Oncology	512	20
advfq_ophtha	Visual Function Questionnaire Analysis	28,798	89
advs	Vital Signs Analysis	65,032	105
advs_metabolic	Vital Signs Analysis for Metabolic	760	101
advs_peds	Vital Signs Analysis for Pediatrics	546	80

SDTM (pharmaverse)

64 datasets from pharmaversesdtm.

Dataset	Label	Rows	Columns
ae	Adverse Events	1,191	35
ae_ophtha	Adverse Events for Ophthalmology	1,191	37
ag_neuro	Procedure Agents Dataset-neuro	68	13
be	Biospecimen Events	43	13
ce_vaccine	Clinical Events for Vaccine	44	29
cm	Concomitant Medication	7,510	22
dm	Demography	306	28
dm_metabolic	Demographic Dataset-metabolic	5	28
dm_neuro	Demographic Dataset-neuro	15	28
dm_peds	Demographic Dataset-pediatrics	5	28
dm_vaccine	Demographics for Vaccine	2	30
ds	Disposition	850	13
eg	Electrocardiogram	26,717	23
ex	Exposure	591	17
ex_ophtha	Exposure for Ophthalmology	591	19
ex_vaccine	Exposures for Vaccine	4	19
face_vaccine	Findings About Clinical Events for Vaccine	307	30
is_ada	Immunogenicity Specimen Assessments for ADA	691	27
is_vaccine	Immunogenicity Specimen Assessments for Vaccine	16	24
lb	Laboratory Measurements	59,580	23
lb_metabolic	Laboratory Measurements Dataset-metabolic	309	24
lb_neuro	Laboratory Test Dataset-neuro	151	23
lb_onco_pcwg3	Laboratory Measurements (PSA) for Oncology	41	18
mb	Microbiology Specimen	18	21
mh	Medical History	1,818	28
ms	Microbiology Susceptibility	47	23
nv_neuro	Neurological Assessment Dataset-neuro	98	21
oe_ophtha	Ophthalmic Examinations for Ophthalmology	26,852	25
pc	Pharmacokinetic Concentrations	4,572	21
pp	Pharmacokinetic Parameters	2,688	14
qs_metabolic	Questionnaire Dataset-metabolic	966	18
qs_ophtha	Questionnaire for Ophthalmology	348	20
rs_onco	Disease Response for Oncology	5,808	19
rs_onco_ca125	Disease Response (GCIG)	66	13
rs_onco_imwg	Disease Response (IMWG)	65	17
rs_onco_irecist	Disease Response (iRECIST) for Oncology	376	19
rs_onco_lymphoma	Disease Response (Lymphoma Lugano 2014)	68	17
rs_onco_pcwg3	Disease Response (PCWG3) for Oncology	90	14
rs_onco_recist	Disease Response (RECIST 1.1) for Oncology	66	14
sc_ophtha	Subject Characteristic for Ophthalmology	254	12
sdg_db	SDG	16	5
smq_db	Standardized MedDRA Queries	44	6
suppae	Supplemental Adverse Events	1,191	10
suppce_vaccine	Supplemental Qualifiers for Clinical Events for Vaccine	4	9
suppdm	Supplemental Demography	1,197	10
suppdm_vaccine	Supplemental Qualifiers for Demographics for Vaccine	2	9
suppds	Supplemental Disposition	3	9
suppex_vaccine	Supplemental Qualifiers for Exposures for Vaccine	4	9
suppface_vaccine	Supplemental Qualifiers for Findings About for Clinical Events for Vaccine	4	9
suppis_vaccine	Supplemental Qualifiers for Immunogenicity Specimen Assessments for Vaccine	16	10
suppnv_neuro	Supplemental for Neurological Assessment Dataset-neuro	68	10
supprs_onco_ca125	Supplemental Qualifiers for RS_ONCO_CA125	49	9
supprs_onco_imwg	Supplemental Qualifiers for RS_ONCO_IMWG	19	9
supptr_onco	Supplemental Tumor Results for Oncology	55,995	9
sv	Subject Visits	3,559	8
tr_onco	Tumor Results for Oncology	55,995	24
tr_onco_recist	Tumor Results (RECIST 1.1) for Oncology	546	19
ts	Trial Design	33	6
tu_onco	Tumor Identification for Oncology	7,734	18
tu_onco_recist	Tumor Identification (RECIST 1.1) for Oncology	75	16
vs	Vital Signs	29,643	24
vs_metabolic	Vital signs Dataset-metabolic	719	24
vs_peds	Vital signs Dataset-pediatrics	164	26
vs_vaccine	Vital Signs for Vaccine	28	23

ADaM (CDISC pilot)

12 datasets from the CDISC SDTM/ADaM Pilot Project.

Dataset	Label	Rows	Columns
adadas	ADAS-Cog Analysis	12,463	40
adae	Adverse Events Analysis Dataset	1,191	55
adcibc	CIBIC+ Analysis	730	36
adlbc	Analysis Dataset Lab Blood Chemistry	37,132	46
adlbcpv	Analysis Dataset Lab Blood Chemistry (Previous Visit)	37,132	46
adlbh	Analysis Dataset Lab Hematology	24,966	46
adlbhpv	Analysis Dataset Lab Hematology (Previous Visit)	24,966	46
adlbhy	Analysis Dataset Lab Hy’s Law	9,954	43
adnpix	NPI-X Item Analysis Data	31,140	41
adsl	Subject-Level Analysis	254	49
adtte	AE Time To 1st Derm. Event Analysis	254	26
advs	Vital Signs Analysis Dataset	32,139	35

SDTM (CDISC pilot)

31 datasets from the CDISC SDTM/ADaM Pilot Project.

Dataset	Label	Rows	Columns
ae	Adverse Events	961	37
cm	Concomitant Medications	7,510	23
dm	Demographics	306	25
ds	Disposition	596	15
ex	Exposure	591	18
lbch	Laboratory Tests Results	32,740	24
lbhe	Laboratory Tests Results	21,927	24
lbur	Laboratory Tests Results	4,913	24
mh	Medical History	1,817	19
qsco	Questionnaires	12,241	23
qsda	Questionnaires	32,920	23
qsgi	Questionnaires	562	23
qshi	Questionnaires	3,302	23
qsmm	Questionnaires	1,524	23
qsni	Questionnaires	71,200	23
relrec	Related Records	211	7
sc	Subject Characteristics	254	14
se	Subject Elements	752	12
suppae	Supplemental Qualifiers for AE	961	10
suppdm	Supplemental Qualifiers for DM	1,197	10
suppds	Supplemental Qualifiers for DS	3	10
supplbch	Supplemental Qualifiers for LB	37,124	10
supplbhe	Supplemental Qualifiers for LB	24,558	10
supplbur	Supplemental Qualifiers for LB	2,721	10
sv	Subject Visits	3,559	12
ta	Trial Arms	11	10
te	Trial Elements	7	7
ti	Trial Inclusion/ Exclusion Criteria	31	5
ts	Trial Summary	48	10
tv	Trial Visits	21	8
vs	Vital Signs	29,643	25